SGN-1

DB18135InvestigationalOrganism Based Therapies

SGN-1 is a genetically modified strain of Salmonella enterica comprising methioninase.

Mechanism: Pharmacologically active on L-methionine gamma-lyase
Curator reviewed
Also known as: SalMet-Vec
Code names: SGN 1

Resolves to

Compound

Targets

What you can answer from here — as of July 08, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

1Clinical trialPhase, status and sponsor resolved per trial

2+ReferencesStructured and connected to the statements they support

Which drugs share a target with SGN-1, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.